Video
Six Top Predictions for Biotech in 2024
In a Fireside Chat during the 2024 JP Morgan Healthcare Conference, Catalent President & CEO Alessandro Maselli shared his predictions for 2024 and his thoughts on the top risks and opportunities in Biotech with Endpoints News Editor John Carroll.
View Now
Video
Developing and Manufacturing Highly Potent APIs
Summary: With integrated formulation development, analytical testing, clinical supply and commercial manufacturing solutions for highly potent products, we can help accelerate your program and bring transformative therapies to patients in need.
View Now
Webinars
Advancing Lipid-Based Formulations and Softgels in Drug Development
Summary: This webinar explores formulation and manufacturing strategies, enriched by case studies on lipid-based drug delivery systems and softgels.
View Now
Webinars
Innovations in Orally Disintegrating Tablets for Pediatric Drug Delivery
Summary: This webinar explores the world of pediatric dosage forms and how ODTs are emerging as a specialized drug delivery system for children.
View Now
Executive Summary
Small Molecule Orphan Drugs: Status Quo, Challenges, and Perspectives
Summary: Experts explore the challenges of orphan drug development and manufacturing and will discuss how the industry is leveraging strategic partnerships to help mitigate these challenges to create a viable orphan drug business model.
View Now
Executive Summary
Targeted Protein Degraders: Through the Lens of the Innovation, Developability, and CMC Challenges
Summary: Experts review the trends and challenges associated with the rational design of targeted protein degrader drugs. In addition, experts also share perspectives on how to inform the selection and development of orally bioavailable...
View Now
Article
Advancing Patient-Centric Drug Delivery for Neurodegenerative Disease with Orally Dissolving Tablets
Summary: Read this article to learn how orally dissolving tablets (ODTs) help address dysphagia concerns and enhance compliance and adherence.
View Now
Webinars
Nitrosamines, Elemental Impurities, Extractable and Leachable – A New Normal for the Pharma Industry
Summary: In this webinar, experts will explore E&L, impurities, and nitrosamines testing regulations, methods, and accelerated pharmaceutical testing.
View Now
Webinars
Adapting to Demand: The Importance of Flexibility in HPAPI Small-Batch Manufacturing
Summary: In this webinar, experts address the challenges posed by manufacturing HPAPIs and suggest strategies to ensure the small-batch flexibility needed for HPAPI manufacturing. Additionally, the panel will discuss various approaches to enhance the efficiency of...
View Now
eBook
Optimizing Highly Potent API Drug Development and Manufacturing
Summary: This eBook explores the challenges and strategies involved in developing and manufacturing HPAPIs as well as highlights the benefits of partnering with an experienced CDMO that can effectively address the challenges of manufacturing potent drugs and...
View Now
